Range Impact Inc (RNGE)

[superchg2]

“Many families who seek alternatives to standard pharmaceuticals, either because of perceived toxicity or because they have had an inadequate response to these drugs, have asked about the use of cannabinoids for the treatment of their IBD,” said Dr. David Ziring, a pediatric gastroenterologist at Cedars-Sinai Medical Center in Los Angeles, Assoc. Director of the Cedars-Sinai Pediatric Inflammatory Bowel Disease Program, and a consultant to Vitality Biopharma. “The prospect of gut-restricted cannabinoids that modulate the local gut immune system but avoid the traditional psychoactive effects of THC is compelling and timely, and could be very well received not only by patients and their families but also by other treating physicians.”

http://vitality.bio/2017/10/vitality-biopharma-announces-positive-results-multiple-cannabinoid-drug-formulations-treatment-ibd/